Table 2 Main, Subcategories, and derivations of physicians’ WSV evaluation
From: Physicians’ assessment of the Bavarian drug-expenditure control system: a qualitative study
Main categories | Subcategories | Derivations |
|---|---|---|
Positive aspects of WSVa | Timely feedback | The introduction of WSV offers only advantages compared to the prescribing target scheme |
Easy to understand | ||
Time-efficient | ||
Stimulating for self-reflection | ||
More control possibilities | ||
More justice | ||
Confidence/Trust in agreement | ||
Negative aspects WSV | Drug discount contracts | Negative evaluation increased when active substance agreement 3.0 was introduced |
Less therapy sovereignty | ||
Lack of transparency | ||
Fear of sanction | ||
Inhibition of innovative drugs | ||
No guideline orientation | ||
The basic structure of trend reports | ||
Concern about successor |